| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.4B | $13.1B | $14.6B | $17.5B | $19.7B | $20.7B | $5.6B | $5.8B |
| Cost of Revenue | $6.6B | $6.7B | $7.1B | $7.9B | $8.5B | $8.9B | $10.1B | $10.9B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.2B | $3.0B | $3.2B | $3.1B | $2.9B | $3.5B | $3.7B | $4.2B |
| Operating Income | $-0.8B | $0.5B | $-9.6B | $0.1B | $4.3B | $1.0B | $0.8B | $-1.8B |
| Net Income | $-1.7B | $-0.1B | $-10.3B | $-1.5B | $2.0B | $-1.2B | $0.2B | $-2.4B |
| EPS (Basic) | $-1.75 | $-0.06 | $-10.48 | $-1.54 | $1.92 | $-1.14 | $0.21 | $-2.26 |
| EPS (Diluted) | $-1.75 | $-0.06 | $-10.48 | $-1.54 | $1.91 | $-1.14 | $0.21 | $-2.26 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $34.3B | $33.5B | $34.0B | $45.6B | $58.0B | $59.4B | $64.7B | $70.3B |
| Current Assets | $7.9B | $4.4B | $4.8B | $5.4B | $11.5B | $3.2B | $4.8B | $3.8B |
| Cash & Equivalents | $1.0B | $1.9B | $2.2B | $1.3B | $0.4B | $0.4B | $1.7B | $0.5B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $4.4B | $3.6B | $3.5B | $4.8B | $7.2B | $6.6B | $7.3B | $5.5B |
| Stockholders' Equity | $-1.1B | $0.5B | $0.4B | $10.4B | $11.8B | $11.2B | $13.5B | $19.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.7B | $4.3B | $2.2B | $4.7B | $6.5B | $6.5B | $6.7B | $7.0B |
| Investing Cash Flow | $-4.3B | $-2.8B | $-1.2B | $5.5B | $-2.7B | $-3.6B | $-3.6B | $-3.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.3B | $-1.9B | $-0.0B | $-9.3B | $-3.8B | $-4.3B | $-1.9B | $-4.0B |